Noninvasive proprietary formulation (Neurelis)

N/A

Report date: 2024/09/24 10:32:18

Base Information

Drug NameNoninvasive proprietary formulation (Neurelis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEpilepsyCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurelis Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurelis Inc
Inactive CompaniesN/A
Active IndicationsEpilepsyCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A